n,n-dimethylarginine has been researched along with Atypical Lipomatous Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, W; Chu, K; Chu, P; Gao, H; Ho, K; Loera, S; Un, F; Wang, J; Wang, Y; Wu, X; Yen, Y; Yuan, YC; Zhang, K | 1 |
1 other study(ies) available for n,n-dimethylarginine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Topics: Adaptor Proteins, Signal Transducing; Arginine; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Extracellular Signal-Regulated MAP Kinases; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Liposarcoma; Male; Membrane Proteins; Middle Aged; Neoplasm Grading; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction | 2013 |